PiPT in ADSM With MSD

NCT05132400 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 427

Last updated 2025-05-11

Study results available
· View outcomes & findings →

Summary

The study objective is to establish feasibility of implementing a psychologically informed rehabilitation strategy while concurrently assessing its' effectiveness in Active duty service members (ADSM) with musculoskeletal disorders (MSD) seeking care in a US Navy shore-based healthcare setting. This intervention is intended to improve the management of chronic pain in order to optimize ADSM function.

The study team is proposing an observational prospective comparative cohort study. This study tests an implementation/strategy while observing/gathering information on the clinical intervention and related outcomes.

Conditions

Interventions

BEHAVIORAL

Psychological-informed Physical Therapy (PiPT) Training

An approach designed to incorporate the concepts of cognitive behavioral therapy (CBT) for pain management into routine clinical PT practice in order to modify maladaptive responses associated with chronicity. The goal of PiPT is to promote a fast and optimal recovery by removing psychological obstacles, obviating the need for referral to a psychologist and facilitating triage to other health professionals in a timely manner when needed. PiPT training includes education about the neuropsychology of pain, patient communication skills, and identification of psychosocial risk factors for chronicity and treatment approaches that include reassurance, relaxation, and psycho-behavioral reactivation.

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED
  • United States Naval Medical Center, Portsmouth

    collaborator FED
  • Henry M. Jackson Foundation for the Advancement of Military Medicine

    collaborator OTHER
  • NYU Langone Health

    lead OTHER

Principal Investigators

  • Marco Campello, PT, PhD · NYU Langone Health

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-28
Primary Completion
2024-06-01
Completion
2024-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05132400 on ClinicalTrials.gov